New Startin T.S. Tablet 80/5/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
MFDS item code 202302812 · Approved 2023.09.25
Treatment of dyslipidemia and hypertension, and inhibition of atherosclerotic progression and cardiovascular disease risk
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure even with the administration of telmisartan and amlodipine combination. Additionally, rosuvastatin is used as an adjunctive treatment for dyslipidemia such as hypercholesterolemia and mixed dyslipidemia when diet and exercise are insufficient. Rosuvastatin particularly helps reduce the risk of cardiovascular disease and delay the progression of atherosclerosis. It contributes to improving cardiovascular health by lowering cholesterol and LDL-cholesterol levels and is also applicable to certain patients with familial hypercholesterolemia. Furthermore, it is effective in reducing the risk of stroke, myocardial infarction, and vascular revascularization. This medication is effective for managing both hypertension and hyperlipidemia and is used in the prevention and treatment of cardiovascular diseases.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking the telmisartan/amlodipine combination together with rosuvastatin as a single agent, they may switch to this drug (a combination product containing the same amount of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this drug 40/10 mg. ◦ Patients with renal impairment: Dose adjustment is not necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended that treatment be initiated at a low dose and that the dose be increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin, and should continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 mg once daily. 2. Older adults: Dose adjustment is not necessary. 3. Patients with renal impairment: Dose adjustment is not necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.
This medication can cause serious harm to the fetus during pregnancy; therefore, if pregnancy is confirmed, discontinue immediately. Do not take if you have an allergy to this medication or similar drugs. Patients with severe liver or kidney impairment, certain heart conditions, and a history of certain genetic muscle disorders should not use this medication. Elderly patients, those with mildly impaired liver function, and patients with significantly low blood pressure or high serum potassium levels should exercise caution when using this medication. If symptoms such as muscle pain, muscle weakness, or cramps occur during treatment, consult a doctor immediately, and tests to check for muscle damage may be necessary. If liver dysfunction is suspected or liver enzyme levels are elevated, discontinue use of this medication and consult a doctor. This medication may interact with other drugs, so it is important to inform your doctor or pharmacist of any other medications you are currently taking. Particular caution should be exercised when used in combination with antihypertensives, diuretics, certain antibiotics, immunosuppressants, and some lipid-lowering agents, as the risk of side effects may increase. Regular blood tests and liver function tests are recommended during treatment. It is not recommended for children or adolescents under 18 years of age, as safety and efficacy have not been adequately established. In case of overdose, symptoms such as hypotension, dizziness, and irregular heartbeats may occur, so seek medical attention immediately and receive appropriate treatment. This medication should be kept out of reach of children, and it is advisable not to transfer it to other containers.
Peripheral edema, dyspepsia, frequent bowel movements, diabetes mellitus, dizziness, dry vesicular sounds, urticaria, unstable angina, onychomycosis, lumbar spinal canal stenosis, ear fluid, vertigo, chronic gastritis, hiatal hernia, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastrointestinal disease, benign gastric neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory decrease, dyskinesia, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory tract infection, low back pain, sinusitis, diarrhea, pharyngitis, flu-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, palpitations, dependence-induced edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, sensory abnormalities, involuntary muscle contractions, sensory decrease, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, diabetes, arthritis, arthralgia, leg numbness, anxiety, depression, hyperreactivity, infection, fungal infection, abscess, otitis media, asthma, bronchitis, rhinitis, dyspnea, nasal bleeding, dermatitis, rash, eczema, pruritus, angioedema, erythema multiforme, vasculitis, thrombocytopenia, leukopenia, purpura, thrombocytopenia, angioedema, hypersensitivity reaction including angioedema, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, erectile dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, angioedema, erythema multiforme, pruritus, rash, erythematous rash, papular rash, angioedema, hypersensitivity reaction including angioedema, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, erectile dysfunction, gynecomastia, hepatic failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, angioedema, erythema multiforme, pruritus, rash, erythematous rash, papular rash, angioedema
Not everyone experiences these, and they can vary from person to person.
This medication is stored in a special container that blocks light and air. When storing, maintain a room temperature between 1 and 30 degrees Celsius. This helps maintain the effectiveness of the medication and prevents degradation.
Oval, bilayer tablet made of white and light blue layers
30 tablets/box [10 tablets/PTPx3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Myeong Mun Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.